//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
Profile
Loading...
Account run by the lab members of the Mass Spectrometry and Proteomics Core Facility of IRB Barcelona ( @irbbarcelona.org ). Follow the link to know us! https://www.irbbarcelona.org/en/research/mass-spectrometry-proteomics
MS Proteomics









Loading...
(3/3) We contributed by generating and analysing the #Proteomics and #PRM data. It's been a pleasure collaborating with you all! #DrugDiscovery #Cancer #KRAS #Proteomics
(2/3) Congratulations to Ines García, @crismayorruiz.bsky.social and all the contributors from the @irbbarcelona.org and from CIC Salamanca behind the recently published in the “Cancer Research” journal @aacrjournals.bsky.social: doi.org/10.1158/0008...
(1/3) Exciting news! The work titled “Targeted KRASG12V Degradation in vivo Elicits Lung Adenocarcinoma Regression with Subsequent Relapse from Dysregulated Proteolysis” demonstrates that eliminating mutated #KRAS with #PROTACs induces rapid tumour regression in mouse models of lung adenocarcinoma.
Thank you to everyone who joined us at the @irbbarcelona.org #OpenDay and visited the MSPCF 🫶 . We love opening our lab doors and sharing the #Research and technologies that drive our daily work. 🔬 It was a real pleasure to spend our #Outreach party with you all! 🥰 See you next year! 🚀
(3/3) Behind-the-scenes visit to our #Proteomics Platform 🔬. Excited to see how these cutting-edge tools will drive new biological discoveries and improve our mechanistic understanding of disease 🧫. #SpatialProteomics #BiomedicalResearch #MassSpec #ScienceEvents
(1/3) Today at @irbbarcelona.org 🧬! We are kicking off the "Next-Generation Spatial Proteomics for Biomedical Research" session! We’re diving deep into the future of 4D proteomics and spatial-omics, exploring how these technologies enable the precise mapping of biomolecules directly within tissues.
🚀Ready to kick-start your scientific career? Join the next #MMRES class! More than 60% of the #MMRES Master's Programme is spent doing hands-on research projects in top #BISTCommunity and MELIS-UPF labs upf.edu/web/mmres
(2/3) Highlights for today: 1️⃣ Welcome by Dra. Marta Vilaseca (@irbbarcelona.org). 2️⃣ Insights on scaling and democratizing spatial tissue proteomics with Dr. Fabian Coscia (@coscialab.bsky.social MDC Berlin, @mdc-berlin.bsky.social). 3️⃣ Pedro Cano (Bruker @brukerspatial.bsky.social).
✨ Join us at #IRBBarcelona Open Day! 📅 Saturday, May 30 A day of science, discovery, and hands-on activities for all ages. 🎟️ Sign up and don’t miss it! 👉 https://bit.ly/4ddD7VA #ExperimentaIRB
📢 #KRAS degradation induces rapid lung #cancer regression in preclinical mouse models: A study by #IRBBarcelona & @ciccancer.bsky.social demonstrates that eliminating mutated KRAS protein using #PROTACs induces rapid tumour regression in mouse models of lung adenocarcinoma. ➡️ https://bit.ly/4dFWhm1
6d
6d
6d
8d
23d
23d
23d
28d
20d
15d
Abstract. Recent drug discovery breakthroughs led to the approval of KRASG12C inhibitors in lung adenocarcinoma (LUAD). Unfortunately, clinical responses are often hampered by the rapid resistance ons...
doi.org
Targeted KRASG12V Degradation in vivo Elicits Lung Adenocarcinoma Regression with Subsequent Relapse from Dysregulated Proteolysis
L’any passat va ser brutal... 😍🔬 Vam descobrir plegats com la ciè...
youtu.be
Vine a la Jornada de Portes Obertes de l'IRB Barcelona!
MS Proteomics
MS Proteomics
MS Proteomics
MS Proteomics
MS Proteomics
MS Proteomics
MS Proteomics
BIST-Barcelona Institute of Science and Technology